Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge

Veterinary Research

Volumn 43, Issue 1, 2012, Pages

  Yu, Xia ^a   Jia, Renyong ^a   Huang, Juan ^a   Shu, Bin ^a   Zhu, Dekang ^a   Liu, Qing ^a   Gao, Xinghong ^a   Lin, Meng ^a   Yin, Zhongqiong ^a   Wang, Mingshu ^a   Chen, Shun ^a   Wang, Yin ^a   Chen, Xiaoyue ^a   Cheng, Anchun ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DUCK ENTERITIS VIRUS; ESCHERICHIA COLI; SALMONELLA TYPHIMURIUM;

BACTERIAL TOXIN; DNA VACCINE; ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; HEAT LABILE ENTEROTOXIN, E COLI; HEAT-LABILE ENTEROTOXIN, E COLI; IMMUNOLOGICAL ADJUVANT; LIVE VACCINE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL; ARTICLE; BIRD DISEASE; DOSE RESPONSE; DUCK; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; MARDIVIRUS; MAREK DISEASE; METABOLISM; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PLASMID; RANDOMIZATION; SALMONELLA TYPHIMURIUM; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BACTERIAL TOXINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DUCKS; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; IMMUNITY, MUCOSAL; MARDIVIRUS; MAREK DISEASE; PLASMIDS; POULTRY DISEASES; RANDOM ALLOCATION; SALMONELLA TYPHIMURIUM; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84864688992     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-43-56     Document Type: Article

References (45)

1. Evolution of the herpesviruses. Davison AJ, Vet Microbiol 2002 86 69 88 10.1016/S0378-1135(01)00492-8 11888691 (Pubitemid 34219150)
2. Characterization of the genes encoding UL24, TK and gH proteins from duck enteritis virus (DEV): a proof for the classification of DEV. Li H, Liu S, Kong X, Virus Genes 2006 33 221 227 10.1007/s11262-005-0060-6 16972038 (Pubitemid 44401429)
3. Identification and characterization of the duck enteritis virus UL51 gene. Shen CJ, Cheng AC, Wang MS, Guo YF, Zhao LC, Wen M, Xie W, Xin HY, Zhu DK, Arch Virol 2009 154 1061 1069 10.1007/s00705-009-0407-8 19517212
4. Duck viral enteritis in domestic muscovy ducks in Pennsylvania. Davison S, Converse KA, Hamir AN, Eckroade RJ, Avian Dis 1993 37 1142 1146 10.2307/1591927 8141746 (Pubitemid 2037972)
5. Intestinal mucosal immune response against virulent duck enteritis virus infection in ducklings. Qi XF, Yang XY, Cheng AC, Wang MS, Zhu DK, Jia RY, Luo QH, Chen XY, Res Vet Sci 2009 87 218 225 10.1016/j.rvsc.2009.02.009 19303123
6. Propagation of vaccine strain of duck enteritis virus in a cell line of duck origin as an alternative production system to propagation in embryonated egg. Mondal B, Rasool TJ, Ram H, Mallanna S, Biologicals 2010 38 401 406 10.1016/j.biologicals.2010.01.016 20227293
7. Induction of immune responses in ducks with a DNA vaccine encoding duck plague virus glycoprotein C. Lian B, Cheng A, Wang M, Zhu D, Luo Q, Jia R, Liu F, Han X, Chen X, Virol J 2011 8 214 10.1186/1743-422X-8-214 21569289
8. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. Liu J, Chen P, Jiang Y, Wu L, Zeng X, Tian G, Ge J, Kawaoka Y, Bu Z, Chen H, J Virol 2011 85 10989 10998 10.1128/JVI.05420-11 21865383
9. Standardization of age and route for duck plague vaccine in local ducklings of vaccinated and non-vaccinated parent origin. Kayesh MEH, Khan MSR, Islam MA, Gani MO, Islam MR, Karim MR, Islam MS, Kabir A, Bangl J Vet Med 2008 6 27 30
10. Bacterial ghosts-biological particles as delivery systems for antigens, nucleic acids and drugs. Tabrizi CA, Walcher P, Mayr UB, Stiedl T, Binder M, McGrath J, Lubitz W, Curr Opin Biotechnol 2004 15 530 537 10.1016/j.copbio.2004. 10.004 15560979 (Pubitemid 39551005)
11. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Dietrich G, Bubert A, Gentschev I, Sokolovic Z, Simm A, Catic A, Kaufmann SHE, Hess J, Szalay AA, Goebel W, Nat Biotechnol 1998 16 181 185 9487527 (Pubitemid 28078508)
12. Oral somatic transgene vaccination using attenuated S. typhimurium. Darji A, Guzmán CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S, Cell 1997 91 765 775 10.1016/S0092-8674(00)80465-1 9413986 (Pubitemid 28007733)
13. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Sizemore DR, Branstrom AA, Sadoff JC, Science 1995 270 299 302 10.1126/science.270.5234.299 7569980
14. Bacteria as DNA vaccine carriers for genetic immunization. Schoen C, Stritzker J, Goebel W, Pilgrim S, Int J Med Microbiol 2004 294 319 335 10.1016/j.ijmm.2004.03.001 15532991 (Pubitemid 39381969)
15. Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production. Yang H, Cao S, Huang X, Liu J, Tang Y, Wen X, Vaccine 2009 27 5035 5040 10.1016/j.vaccine.2009.06.050 19573642
16. Salmonella enterica serovar Typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge. Garmory HS, Titball RW, Griffin KF, Hahn U, Bohm R, Beyer W, Infect Immun 2003 71 3831 3836 10.1128/IAI.71.7.3831-3836.2003 12819066 (Pubitemid 36753705)
17. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G, Proc Natl Acad Sci U S A 1995 92 1644 1648 10.1073/pnas.92.5.1644 7878032
18. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T, Vaccine 2007 25 1647 1657 10.1016/j.vaccine.2006.11.010 17188785 (Pubitemid 46108208)
19. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Weltzin R, Guy B, Thomas WD, Giannasca PJ, Monath TP, Infect Immun 2000 68 2775 2782 10.1128/IAI.68.5.2775-2782.2000 10768972 (Pubitemid 30253855)
20. Temporal regulation of herpes simplex virus type 1 UL24 mRNA expression via differential polyadenylation. Cook WJ, Coen DM, Virology 1996 218 204 213 10.1006/viro.1996.0180 8615023 (Pubitemid 26135254)
21. The UL24 consensus regions of bovine herpesvirus 2 isolate 554 and clinical isolates of herpes simplex viruses 1 and 2. Jelic I, May JT, J Gen Appl Microbiol 2003 49 363 366 10.2323/jgam.49.363 14747979 (Pubitemid 38208431)
22. Identification, localization, and regulation of expression of the UL24 protein of herpes simplex virus type 1. Pearson A, Coen DM, J Virol 2002 76 10821 10828 10.1128/JVI.76.21.10821-10828.2002 12368325 (Pubitemid 35176199)
23. A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture. Jacobson JG, Martin SL, Coen DM, J Virol 1989 63 1839 1843 2538662 (Pubitemid 19086004)
24. Cloning, expression, purification and characterization of UL24 partial protein of duck enteritis virus. Jia R, Cheng A, Zhu D, Ge H, Xin H, Liu F, Luo Q, Guo Y, Qi X, Yin Z, Chen X, Intervirology 2009 52 326 334 10.1159/000242354 19786809
25. Sambrook J, Russell DW: Molecular cloning: a laboratory manual CSHL, New York 3 2001
26. A simple method of estimating fifty per cent endpoints. Reed LJ, Muench H, Am J Epidemiol 1938 27 493 497
27. Molecular characterization of the herpes simplex virus 1 (HSV-1) homologues, UL25 to UL30, in duck enteritis virus (DEV). Liu S, Chen S, Li H, Kong X, Gene 2007 401 88 96 10.1016/j.gene.2007.06.022 17706377 (Pubitemid 47379517)
28. DNA vaccines and their applications in veterinary practice: current perspectives. Dhama K, Mahendran M, Gupta PK, Rai A, Vet Res Commun 2008 32 341 356 10.1007/s11259-008-9040-3 18425596
29. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS, Kotlarski I, Jilbert AR, Virology 2006 351 159 169 10.1016/j.virol.2006.02.037 16624364 (Pubitemid 44037654)
30. Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector. Huang JM, Sali M, Leckenby MW, Radford DS, Huynh HA, Delogu G, Cranenburgh RM, Cutting SM, Vaccine 2010 28 7523 7528 10.1016/j.vaccine.2010.09.001 20851079
31. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Davis HL, Brazolot Millan CL, Mancini M, McCluskie MJ, Hadchouel M, Comanita L, Tiollais P, Whalen RG, Michel ML, Vaccine 1997 15 849 852 10.1016/S0264-410X(96)00267-8 9234531 (Pubitemid 27287973)
32. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM, J Immunol 1998 160 870 876 9551923 (Pubitemid 28049329)
33. Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen. Karpenko LI, Nekrasova NA, Ilyichev AA, Lebedev LR, Ignatyev GM, Agafonov AP, Zaitsev BN, Belavin PA, Seregin SV, Danilyuk NK, Vaccine 2004 22 1692 1699 10.1016/j.vaccine.2003.09.050 15068852 (Pubitemid 38447217)
34. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S, Chen M, Schaefer M, Doe B, Otten GR, Ulmer JB, J Virol 2001 75 9037 9043 10.1128/JVI.75.19.9037-9043.2001 11533167 (Pubitemid 32851908)
35. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT, J Leukoc Biol 1997 61 125 132 9021916 (Pubitemid 27081372)
36. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Timares L, Takashima A, Johnston SA, Proc Natl Acad Sci U S A 1998 95 13147 13152 10.1073/pnas.95.22.13147 9789056 (Pubitemid 28509539)
37. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP, Blood 1998 92 3172 3176 9787153 (Pubitemid 28492324)
38. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Martin M, Michalek SM, Katz J, Infect Immun 2003 71 2498 2507 10.1128/IAI.71.5.2498-2507.2003 12704121 (Pubitemid 36519862)
39. A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells. Hopkins S, Niedergang F, Corthesy-Theulaz IE, Kraehenbuhl JP, Cell Microbiol 2000 2 59 68 10.1046/j.1462-5822.2000.00035.x 11207563 (Pubitemid 30225067)
40. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Hopkins S, Kraehenbuhl JP, Schodel F, Potts A, Peterson D, de Grandi P, Nardelli-Haefliger D, Infect Immun 1995 63 3279 3286 7642256
41. Immunopathology of herpes simplex virus infections. Doymaz MZ, Rouse BT, Curr Top Microbiol Immunol 1992 179 121 136 10.1007/978-3-642-77247-4-8 1499346
42. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. Koelle DM, Posavad CM, Barnum GR, Johnson ML, Frank JM, Corey L, J Clin Invest 1998 101 1500 1508 10.1172/JCI1758 9525993 (Pubitemid 28166848)
43. TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection. Morrison VL, Barr TA, Brown S, Gray D, J Immunol 2010 185 2737 2746 10.4049/jimmunol.1000758 20660707
44. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Holmgren J, Lycke N, Czerkinsky C, Vaccine 1993 11 1179 1184 10.1016/0264-410X(93)90039-Z 8256498 (Pubitemid 23308772)
45. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. Elson CO, Ealding W, J Immunol 1984 132 2736 2741 6233359 (Pubitemid 14105650)